Showing results (1611-1620 of 1,799) with videos related to

Sort By:
Pageof 180
Mabs|January 3, 2022
Non-targeted characterization of attributes affecting antibody-FcγRIIIa V158 (CD16a) binding via online affinity chromatography-mass spectrometryDaniel W Woodall, Thomas M Dillon, Kevin Kalenian, et al.
Mabs|October 26, 2022
Insights into ultra-low affinity lipase-antibody noncovalent complex binding mechanismsElizabeth Sara Hecht, Shrenik Mehta, Aaron T Wecksler, et al.
Mabs|April 16, 2019
An in vitro FcRn- dependent transcytosis assay as a screening tool for predictive assessment of nonspecific clearance of antibody therapeutics in humansShan Chung, Van Nguyen, Yuwen Linda Lin, et al.
Mabs|June 1, 2019
CDR-H3 loop ensemble in solution - conformational selection upon antibody bindingMonica L Fernández-Quintero, Johannes Kraml, Guy Georges, et al.
Mabs|October 25, 2021
Novel chimeric monoclonal antibodies that block fentanyl effects and alter fentanyl biodistribution in miceBhupal Ban, Rodell C Barrientos, Therese Oertel, et al.
Mabs|February 8, 2022
Discovery and characterization of a monoclonal antibody targeting a conformational epitope of IL-6/IL-6Rα to inhibit IL-6/ IL-6Rα/gp130 hexameric signaling complex formationChun-Chi Chou, Kuo-Tai Hua, Min-Wei Chen, et al.
Mabs|October 18, 2021
Antibody mix-and-read assays based on fluorescence intensity probesUjwal Patil, Atul Goyal, Binh Vu, et al.
Mabs|October 22, 2021
Fc gamma receptor IIIb binding of individual antibody proteoforms resolved by affinity chromatography-mass spectrometrySteffen Lippold, Alexander Knaupp, Arnoud H de Ru, et al.
Mabs|February 1, 2022
Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeuticsRahul Khetan, Robin Curtis, Charlotte M Deane, et al.
Mabs|January 24, 2022
Epitope mapping of anti-drug antibodies to a clinical candidate bispecific antibodyArthur J Schick, Victor Lundin, Justin Low, et al.
Pageof 180